Review



4 peg2 azide  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress 4 peg2 azide
    4 Peg2 Azide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/Pomalidomide+4'-PEG2-azide/10__1038_slash_s41598___026___74569___2-249-6-22
    Average 94 stars, based on 1 article reviews
    4 peg2 azide - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: eIF4E and Ezrin cooperate in pseudopods to drive a localized migratory translation program in acute myeloid leukemia
    Article Snippet: Cells were then washed three times with RL buffer and blocked for 30 minutes at RT with 2% BSA with 2mg/ml Biotin (cat# B1595, Invitrogen) in RL buffer. .. After washing three times with RL buffer, cells were incubated for 1 hour at RT with 50mM Biotinylated Puromycin (cat# 2379889-82-2, MedChemExpress) in RL buffer with 2% BSA. .. After washing three times with RL buffer, cells were incubated with 2mg/ml NeutrAvidin Oregon Green 488 (cat# A6374, Invitrogen) in 2% BSA in RL buffer for 1 hour at RT, washed three times with RL buffer and either mounted in ProLong TM gold antifade media with DAPI, or stained for proteins as indicated in the text.

    Article Title: Covalently targeting HSP90 with a natural small-molecule costunolide to inhibit necroptosis and ulcerative colitis.
    Article Snippet: Background: Necroptosis exacerbates ulcerative colitis (UC) by disrupting intestinal barriers and promoting necroinflammation.. Heat shock protein 90 (HSP90) regulates receptor-interacting protein kinase 1/3 (RIPK1/3) activity through its chaperone function, thereby participating in necroptosis and emerging as a potential therapeutic target for its inhibition in UC therapy.. Costunolide (CTL), a principal sesquiterpene lactone from Aucklandia lappa, has poorly defined mechanisms in UC treatment.

    Protein Concentration:

    Article Title: Covalently targeting HSP90 with a natural small-molecule costunolide to inhibit necroptosis and ulcerative colitis.
    Article Snippet: Background: Necroptosis exacerbates ulcerative colitis (UC) by disrupting intestinal barriers and promoting necroinflammation.. Heat shock protein 90 (HSP90) regulates receptor-interacting protein kinase 1/3 (RIPK1/3) activity through its chaperone function, thereby participating in necroptosis and emerging as a potential therapeutic target for its inhibition in UC therapy.. Costunolide (CTL), a principal sesquiterpene lactone from Aucklandia lappa, has poorly defined mechanisms in UC treatment.

    CTL Assay:

    Article Title: Covalently targeting HSP90 with a natural small-molecule costunolide to inhibit necroptosis and ulcerative colitis.
    Article Snippet: Background: Necroptosis exacerbates ulcerative colitis (UC) by disrupting intestinal barriers and promoting necroinflammation.. Heat shock protein 90 (HSP90) regulates receptor-interacting protein kinase 1/3 (RIPK1/3) activity through its chaperone function, thereby participating in necroptosis and emerging as a potential therapeutic target for its inhibition in UC therapy.. Costunolide (CTL), a principal sesquiterpene lactone from Aucklandia lappa, has poorly defined mechanisms in UC treatment.

    Generated:

    Article Title: Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer.
    Article Snippet: An H-score > 50 was used as the threshold for sclerostin positivity.34 Preparation of sclerostin aptamer-based PROTACs In the plastic reaction tube, 5′-alkyne sclerostin aptamer Apc001OA or Cy3-labled Apc001OA (1.0 eq),18 azide linked-VHL/CRBN/ MDM2 ligand ((S, R, S)-AHPC-PEG4-N3, MedChemExpress, Cat: HY-103601) (Thalidomide-O-PEG4-azide, MedChemExpress, Cat: HY-140844) (Nutlin-C1-amido-PEG4-C2-N3, MedChemExpress, Cat: HY-128832) or azide linked-VHL ligands with different linkers (100 eq), and Copper (II) sulfate pentahydrate (Sigma-AIdrich, Cat: 469130) (50 eq) were transferred. .. For the azide linkedVHL ligands with different linkers, which were generated by mixing the azide-linker-NHS esters (N3-PEG2-C2-NHS ester, leyan, Cat: 1175728) (N3-PEG4-CH2COONHS, ACHEMBLOCK, Cat: V156175) (Azido-PEG6-NHS ester, BROADPHARM, Cat: BP21506) (Azido-PEG8-NHS ester, BROADPHARM, Cat: BP-215606) (Azido-PEG10-NHS ester, BROADPHARM, Cat: BP-23998) (1.0 eq), NH2-VHL ligand ((S, R, S)-AHPC, MedChemExpress, Cat: HY-125845) ((2S,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl) benzyl)pyrrolidine-2-carboxamide hydrochloride, bidepharm, Cat: BD01272772) (1.5 eq), and N,NDiisopropylethylamine (MACKLIN, Cat: N741860) (1.5 eq) in DMSO for 4 h, respectively. ..

    Article Title: Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer
    Article Snippet: After blocking (Beyotime, Cat: P0260), the sections were incubated overnight at 4°C with the primary antibodies against sclerostin (Thermo Fisher Scientific, Cat: PA5-113315; 1:500) or Ki-67 (Proteintech, Cat: 27309-1-AP; 1:500), followed by horseradish peroxidase (HRP)-conjugated secondary antibodies (Gene Tech, Cat: GK500710). .. For the azide linked-VHL ligands with different linkers, which were generated by mixing the azide-linker-NHS esters (N3-PEG2-C2-NHS ester, leyan, Cat: 1175728) (N3-PEG4-CH2COONHS, ACHEMBLOCK, Cat: V156175) (Azido-PEG6-NHS ester, BROADPHARM, Cat: BP-21506) (Azido-PEG8-NHS ester, BROADPHARM, Cat: BP-215606) (Azido-PEG10-NHS ester, BROADPHARM, Cat: BP-23998) (1.0 eq), NH 2 -VHL ligand ((S, R, S)-AHPC, MedChemExpress, Cat: HY-125845) ((2S,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl) benzyl)pyrrolidine-2-carboxamide hydrochloride, bidepharm, Cat: BD01272772) (1.5 eq), and N,N-Diisopropylethylamine (MACKLIN, Cat: N741860) (1.5 eq) in DMSO for 4 h, respectively. ..

    Magnetic Beads:

    Article Title: Spatiotemporally controlled ferritin-targeting PROTAC nanoplatform for visualized manipulation of endogenous “Iron pool” in pancreatic cancer therapy
    Article Snippet: Ammonium fluoride (NH 4 F) and 4-toluene sulfonic acid were obtained from Macklin (Shanghai, China). .. Fluorescamine, H 2 N-PEG 2 -CH 2 COOH, (S,R,S)-AHPC-Me hydrochloride (VHL ligand), fluorescein isothiocyanate (FITC), 1,3-diphenylisobenzofuran (DPBF), BODIPY581/591-C11, FerroOrange, MG132 and Protein A/G IP Magnetic Beads were purchased from MedChemExpress LLC (Shanghai, China). .. Dichloromethane (DCM), N,N -dimethylformamide (DMF) were obtained from Sinopharm Chemical Reagent Co., Ltd (Shanghai, China).



    Similar Products

    94
    MedChemExpress 4 peg2 azide
    4 Peg2 Azide, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/Pomalidomide+4'-PEG2-azide/10__1038_slash_s41598___026___74569___2-249-6-22
    Average 94 stars, based on 1 article reviews
    4 peg2 azide - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    TargetMol biotin peg2 c2 iodoacetamide
    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on <t>Biotin-PEG2-C2-iodoacetamide</t> labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)
    Biotin Peg2 C2 Iodoacetamide, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/Biotin-PEG2-C2-iodoacetamide/pmc13057077-361-8-9
    Average 94 stars, based on 1 article reviews
    biotin peg2 c2 iodoacetamide - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress thalidomide o peg2 propargyl
    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on <t>Biotin-PEG2-C2-iodoacetamide</t> labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)
    Thalidomide O Peg2 Propargyl, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/Thalidomide-O-PEG2-propargyl/10__1038_slash_s41598___026___74569___2-249-3-22
    Average 94 stars, based on 1 article reviews
    thalidomide o peg2 propargyl - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Thermo Fisher ez link maleimide peg2 biotin
    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on <t>Biotin-PEG2-C2-iodoacetamide</t> labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)
    Ez Link Maleimide Peg2 Biotin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/(%2B)-Biotin+N-hydroxysuccinimide+ester%2C+98%25/pm42213404-198-5-6
    Average 96 stars, based on 1 article reviews
    ez link maleimide peg2 biotin - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress azide linker nhs esters
    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on <t>Biotin-PEG2-C2-iodoacetamide</t> labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)
    Azide Linker Nhs Esters, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/N3-PEG2-C2-NHS+ester/pmc13198293-442-14-49
    Average 94 stars, based on 1 article reviews
    azide linker nhs esters - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Tokyo Chemical Industry biotin peg2 nhs ester
    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on <t>Biotin-PEG2-C2-iodoacetamide</t> labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)
    Biotin Peg2 Nhs Ester, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/bdp+ester+fl+nhs/pm42086734-236-4-6
    Average 86 stars, based on 1 article reviews
    biotin peg2 nhs ester - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress n3 peg4 ch2coonhs
    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on <t>Biotin-PEG2-C2-iodoacetamide</t> labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)
    N3 Peg4 Ch2coonhs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/N3-PEG2-C2-NHS+ester/pm42030934-580-21-47
    Average 94 stars, based on 1 article reviews
    n3 peg4 ch2coonhs - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Macklin Inc biotin peg2 amine
    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on <t>Biotin-PEG2-C2-iodoacetamide</t> labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)
    Biotin Peg2 Amine, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/peg2/glycol+polyethylene/pmc13130684-423-22-24
    Average 86 stars, based on 1 article reviews
    biotin peg2 amine - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    Image Search Results


    Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on Biotin-PEG2-C2-iodoacetamide labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)

    Journal: Signal Transduction and Targeted Therapy

    Article Title: BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axis

    doi: 10.1038/s41392-026-02644-1

    Figure Lengend Snippet: Characterization of IHMT-15137 as a potent and selective BMX inhibitor. a Chemical structure of IHMT-15137 and its reversible analog IHMT-15138. b Determination of the IC 50 values of IHMT-15137, IHMT-15138 and ibrutinib against the BMX protein via the ADP-Glo kinase assay. c Anti-proliferative activity of IHMT-15137, IHMT-15138 and ibrutinib against TEL-BaF3-BMX cells determined by the CTG assay. d CETSA analysis of the effects of IHMT-15137 on BMX protein stability in H446DDPR and H69AR cell lysates: temperature- and dose-dependent stabilization of BMX by IHMT-15137. The right panels show the results of the quantitative analysis of the BMX protein levels from the Western blots. e DARTS assay confirmation of the direct binding of IHMT-15137 to BMX by assessing the stability of BMX against pronase-mediated proteolysis in H446DDPR and H69AR cell lysates. f Inhibitory effects of IHMT-15137 and IHMT-15138 on BMX phosphorylation (Tyr566) in TEL-BaF3-BMX cells after 4 h of treatment, as determined by Western blotting. g Inhibitory effects of 12 h of IHMT-15137 treatment on BMX phosphorylation (Tyr566) and its downstream signaling pathways in H446DDPR and H69AR cells. h Molecular docking analysis of the irreversible binding mode of IHMT-15137 with BMX (PDB ID: 3SXR). i Effect of IHMT-15137 on Biotin-PEG2-C2-iodoacetamide labeling of BMX via a competitive biotin-iodoacetamide assay. Data were presented as mean ± SEM ( n = 3)

    Article Snippet: Subsequently, the samples were incubated with 8 mM Biotin‐PEG2‐C2‐iodoacetamide (TargetMol, Shanghai, China; Cat. No. T17565 ) for 4 h at room temperature in the dark.

    Techniques: Kinase Assay, Activity Assay, CTG Assay, Western Blot, Binding Assay, Phospho-proteomics, Protein-Protein interactions, Labeling